{
    "clinical_study": {
        "@rank": "83971", 
        "arm_group": [
            {
                "arm_group_label": "IPT+antidepressant drugs", 
                "arm_group_type": "Experimental", 
                "description": "Interpersonal Psychotherapy protocol (IPT) consist of 16 sessions of manualized interpersonal psychotherapy for depression. Patients are allowed to reschedule 3 sessions if they miss their appointments.\nAntidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician\u00b4s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetin, citalopram, escitalopram, fluvoxamine, venlafaxin, duloxetin, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride."
            }, 
            {
                "arm_group_label": "Antidepressant Drugs", 
                "arm_group_type": "Active Comparator", 
                "description": "Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician\u00b4s free choice.\nAntidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician\u00b4s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine, venlafaxine, duloxetine, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether combination of antidepressant drugs plus\n      interpersonal psychotherapy is superior to antidepressant drugs alone in treatment resistant\n      depression."
        }, 
        "brief_title": "Interpersonal Psychotherapy for Treatment Resistant Depression", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Treatment Resistant Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary diagnose of unipolar treatment resistant depression\n\n        Exclusion Criteria:\n\n          -  Patients diagnose of: bipolar disorder, psychosis, high suicide risk, Intellectual\n             disability, illicit drug dependence.\n\n          -  Currently in or having received psychotherapy in the last 4 weeks"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "74", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01896349", 
            "org_study_id": "TIP-120288"
        }, 
        "intervention": [
            {
                "arm_group_label": "IPT+antidepressant drugs", 
                "description": "16 sessions of interpersonal psychotherapy plus antidepressant drugs.", 
                "intervention_name": "IPT+ antidepressant drugs", 
                "intervention_type": "Other", 
                "other_name": [
                    "Interpersonal Psychotherapy", 
                    "Antidepressant drugs"
                ]
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "description": "Antidepressant drugs, clinician\u00b4s free choice oriented by guidelines. Monotherapy or combinations are allowed", 
                "intervention_name": "fluoxetine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "sertraline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "paroxetine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Citalopram", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "escitalopram", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "fluvoxamine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Venlafaxine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Duloxetine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Bupropion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Lithium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Risperidone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "tranylcypromine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Imipramine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "amitriptyline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Clomipramine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "nortriptyline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "trazodone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "Mirtazapine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "IPT+antidepressant drugs", 
                    "Antidepressant Drugs"
                ], 
                "intervention_name": "sulpiride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Trazodone", 
                "Tranylcypromine", 
                "Fluvoxamine", 
                "Clomipramine", 
                "Citalopram", 
                "Fluoxetine", 
                "Paroxetine", 
                "Sertraline", 
                "Venlafaxine", 
                "Duloxetine", 
                "Sulpiride", 
                "Bupropion", 
                "Amitriptyline", 
                "Antidepressive Agents", 
                "Imipramine", 
                "Nortriptyline", 
                "Mirtazapine", 
                "Amitriptyline, perphenazine drug combination", 
                "Dexetimide", 
                "Lithium", 
                "Risperidone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Psychotherapy, Treatment Resistant Depression, depression", 
        "lastchanged_date": "July 10, 2013", 
        "location": {
            "contact": {
                "email": "livia.hs@terra.com.br", 
                "last_name": "L\u00edvia H Souza, MD", 
                "phone": "+55 5198658701"
            }, 
            "contact_backup": {
                "email": "mfleck.voy@terra.com.br", 
                "last_name": "Marcelo PA Fleck, MD, PhD", 
                "phone": "+55 51 33598294"
            }, 
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "RS", 
                    "zip": "90035-003"
                }, 
                "name": "Federal University of Rio Grande do Sul / Hospital de Cl\u00ednicas de Porto Alegre (HCPA)"
            }, 
            "investigator": [
                {
                    "last_name": "L\u00edvia H Souza, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Marcelo PA Fleck, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Marco Antonio K Caldieraro, MD, MSc", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lucas Spanemberg, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Edgar A Vares, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Interpersonal Psychotherapy in Treatment Resistant Depression", 
        "other_outcome": [
            {
                "measure": "Clinical Global Impression - Severity Scale (CGI-S) / dichotomous", 
                "safety_issue": "No", 
                "time_frame": "Endpoint (week-19) and week 24"
            }, 
            {
                "description": "Score change in Whoqol-breef from baseline to week 19 and week 24", 
                "measure": "Whoqol brief - World Health Organization Quality of Life Instrument - Short version - Brazilian version", 
                "safety_issue": "No", 
                "time_frame": "Endpoint week 19 and week 24"
            }, 
            {
                "description": "A blood sample will be collected at baseline, week 19 and week 24. Change in serum biomarkers will be evaluated - BDFN (Brain derived neurotrophic factor), TBARS (thiobarbituric acid reactive substance), TNF-alfa (tumor necrosis factor alfa), IL-1 (interleukin-1), IL-6 (interlekin-6) before and after treatment.", 
                "measure": "Biological measures - BDFN, TBARS, TNF-alfa, IL-1, IL-6", 
                "safety_issue": "Yes", 
                "time_frame": "End point week 19 and Week 24"
            }
        ], 
        "overall_contact": {
            "email": "liviahartmanndesouza@gmail.com", 
            "last_name": "Livia H Souza, MD", 
            "phone": "+55 51 98658701"
        }, 
        "overall_contact_backup": {
            "email": "mfleck.voy@terra.com.br", 
            "last_name": "Marcelo PA Fleck, PhD", 
            "phone": "+55 51 33598294"
        }, 
        "overall_official": {
            "affiliation": "Federal University of Rio Grande do Sul / Hospital de Cl\u00ednicas de Porto Alegre", 
            "last_name": "Marcelo PA Fleck, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: Ethics Committee", 
                "Brazil: National Committee of Ethics in Research"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Score change on Hamilton depression scale from baseline to week 19 and to week 24", 
            "measure": "Hamilton Depression Scale (HAM-D) - continuous", 
            "safety_issue": "No", 
            "time_frame": "End point week 19 and Week 24"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01896349"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Score change on Beck depression inventory from baseline to week 19 and to week 24", 
            "measure": "Beck depression Inventory (BDI)", 
            "safety_issue": "No", 
            "time_frame": "End point week 19 and Week 24"
        }, 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}